BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30273379)

  • 21. Quinone reductase (QR) inducers from Andrographis paniculata and identification of molecular target of andrographolide.
    Yuan Y; Ji L; Luo L; Lu J; Ma X; Ma Z; Chen Z
    Fitoterapia; 2012 Dec; 83(8):1506-13. PubMed ID: 22960348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
    Hayes JD; McMahon M; Chowdhry S; Dinkova-Kostova AT
    Antioxid Redox Signal; 2010 Dec; 13(11):1713-48. PubMed ID: 20446772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CACUL1/CAC1 Regulates the Antioxidant Response by Stabilizing Nrf2.
    Kigoshi Y; Fukuda T; Endo T; Hayasaka N; Iemura S; Natsume T; Tsuruta F; Chiba T
    Sci Rep; 2015 Aug; 5():12857. PubMed ID: 26238671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3.
    Rachakonda G; Xiong Y; Sekhar KR; Stamer SL; Liebler DC; Freeman ML
    Chem Res Toxicol; 2008 Mar; 21(3):705-10. PubMed ID: 18251510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
    Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sp1 is a substrate of Keap1 and regulates the activity of CRL4A
    Siswanto FM; Oguro A; Imaoka S
    J Biol Chem; 2021; 296():100704. PubMed ID: 33895141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications.
    Keum YS
    Ann N Y Acad Sci; 2011 Jul; 1229():184-9. PubMed ID: 21793854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants.
    Dinkova-Kostova AT; Kostov RV; Canning P
    Arch Biochem Biophys; 2017 Mar; 617():84-93. PubMed ID: 27497696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prothymosin-alpha mediates nuclear import of the INrf2/Cul3 Rbx1 complex to degrade nuclear Nrf2.
    Niture SK; Jaiswal AK
    J Biol Chem; 2009 May; 284(20):13856-13868. PubMed ID: 19279002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.
    Ichikawa T; Li J; Meyer CJ; Janicki JS; Hannink M; Cui T
    PLoS One; 2009 Dec; 4(12):e8391. PubMed ID: 20027226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1.
    Lo SC; Hannink M
    Mol Cell Biol; 2006 Feb; 26(4):1235-44. PubMed ID: 16449638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a High-Throughput Cul3-Keap1 Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for Identifying Nrf2 Activators.
    Poore DD; Hofmann G; Wolfe LA; Qi H; Jiang M; Fischer M; Wu Z; Sweitzer TD; Chakravorty S; Donovan B; Li H
    SLAS Discov; 2019 Feb; 24(2):175-189. PubMed ID: 30383469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation.
    Hong F; Sekhar KR; Freeman ML; Liebler DC
    J Biol Chem; 2005 Sep; 280(36):31768-75. PubMed ID: 15985429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.
    Davies TG; Wixted WE; Coyle JE; Griffiths-Jones C; Hearn K; McMenamin R; Norton D; Rich SJ; Richardson C; Saxty G; Willems HM; Woolford AJ; Cottom JE; Kou JP; Yonchuk JG; Feldser HG; Sanchez Y; Foley JP; Bolognese BJ; Logan G; Podolin PL; Yan H; Callahan JF; Heightman TD; Kerns JK
    J Med Chem; 2016 Apr; 59(8):3991-4006. PubMed ID: 27031670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation Spectroscopy.
    Yoshizaki Y; Mori T; Ishigami-Yuasa M; Kikuchi E; Takahashi D; Zeniya M; Nomura N; Mori Y; Araki Y; Ando F; Mandai S; Kasagi Y; Arai Y; Sasaki E; Yoshida S; Kagechika H; Rai T; Uchida S; Sohara E
    Sci Rep; 2017 Jun; 7(1):3945. PubMed ID: 28638054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer.
    Martinez VD; Vucic EA; Thu KL; Pikor LA; Lam S; Lam WL
    Head Neck; 2015 May; 37(5):727-34. PubMed ID: 24596130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of human Keap1 S53 and S293 residues in modulating the binding of Keap1 to Nrf2.
    Wei S; Pei Y; Wang Y; Guan H; Huang Y; Xing T; Johnson RW; Wang D
    Biochimie; 2019 Mar; 158():73-81. PubMed ID: 30576774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway.
    Heyninck K; Sabbe L; Chirumamilla CS; Szarc Vel Szic K; Vander Veken P; Lemmens KJA; Lahtela-Kakkonen M; Naulaerts S; Op de Beeck K; Laukens K; Van Camp G; Weseler AR; Bast A; Haenen GRMM; Haegeman G; Vanden Berghe W
    Biochem Pharmacol; 2016 Jun; 109():48-61. PubMed ID: 27045103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.